REV-ERB activation as a novel pharmacological approach for treating inflammatory pain.

Saved in:

Bibliographic Details
Title:	REV-ERB activation as a novel pharmacological approach for treating inflammatory pain.
Authors:	Makhija S; Department of Anatomy, Physiology, and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, United States., Griffett JD; Department of Anatomy, Physiology, and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, United States., Veerakanellore GB; Center for Clinical Pharmacology, Washington University School of Medicine, University of Health Sciences & Pharmacy, St. Louis, MO, United States.; Department of Pharmaceutical and Administrative Sciences, University of Health Sciences & Pharmacy, St. Louis, MO, United States., Burris TP; University of Florida Genetics Institute, Gainesville, FL, United States., Elgendy B; Center for Clinical Pharmacology, Washington University School of Medicine, University of Health Sciences & Pharmacy, St. Louis, MO, United States.; Department of Pharmaceutical and Administrative Sciences, University of Health Sciences & Pharmacy, St. Louis, MO, United States., Griffett K; Department of Anatomy, Physiology, and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, United States.
Source:	Frontiers in pharmacology [Front Pharmacol] 2023 Apr 19; Vol. 14, pp. 1171931. Date of Electronic Publication: 2023 Apr 19 (Print Publication: 2023).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1663-9812
DOI:	10.3389/fphar.2023.1171931